- Exchange: SIX Swiss Ex
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Newron Pharmaceuticals SpA+ Add to Watchlist
NWRN:SW16.60 CHF 0.80 4.60%
As of 08:48:18 ET on 12/06/2013.
Company Profile for Newron Pharmaceuticals SpA (NWRN)
Newron Pharmaceuticals SpA is a research and development biopharmaceutical company. The Company focuses on and develops therapies for the Central Nervous System (CNS) in cases such as Parkinson's disease, neuropathic low back pain and other cognitive disorders.
Newron Pharmaceuticals SpA
Key Executives for Newron Pharmaceuticals SpA (NWRN)
|Stefan WeberCEO/CFO||Marco CaremiExec VP:Business Development|
|Ravi AnandChief Medical Officer||Roberto GalliVP:Finance|
|Anders HaegerstrandMember-Mgmt Board|